Volume 43, Issue 41, 1 November 2022

Issue @ A Glance

Sodium–glucose co-transporter 2 inhibition: the saga continues

Filippo Crea

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4215–4218, https://doi.org/10.1093/eurheartj/ehac590

• Extract
• View article

Cardiopulse

Empagliflozin in patients hospitalized for acute heart failure

Piotr Ponikowski and Jan Biegus

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4219–4221, https://doi.org/10.1093/eurheartj/ehac427

• Extract
• View article

The promise and pitfalls of novel cuffless blood pressure devices

Aletta E Schutte

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4222–4223, https://doi.org/10.1093/eurheartj/ehac474

• Extract
• View article

Resounding victory in golf of the Continental Europe Team of Cardiology

Peter J Schwartz and others

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4224–4226, https://doi.org/10.1093/eurheartj/ehac392

• Extract
• View article

Cardiopulse

Weekly Journal Scan

Combination of ezetimibe and moderate-intensity statin for patients with atherosclerotic cardiovascular disease: a paradigm shift in lipid management landscape

Daniela Pedicino and Massimo Volpe

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4227–4228, https://doi.org/10.1093/eurheartj/ehac502

• Extract
• View article

ESC Guidelines

Guidelines

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)

Alexander R Lyon and others

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4229–4361, https://doi.org/10.1093/eurheartj/ehac244

• Extract
• View article
• Supplementary data

Fast Track Clinical Research

Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial

Javed Butler and others

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4362–4373, https://doi.org/10.1093/eurheartj/ehac401

• Abstracts
• View article
• Supplementary data

Editorial

Potassium binders for patients with heart failure? The real enlightenment of the DIAMOND trial

Milton Packer

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4374–4377, https://doi.org/10.1093/eurheartj/ehac399

• Abstract
• View article

Fast Track Clinical Research

Editor's Choice

Influenza vaccination strategy in acute coronary syndromes: the VIP-ACS trial

Henrique Andrade R Fonseca and others

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4378–4388, https://doi.org/10.1093/eurheartj/ehac472

• Abstracts
• View article
• Supplementary data

Editorial

Influenza vaccine in cardiovascular disease: time to move the needle

Orly Vardeny

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4389–4391, https://doi.org/10.1093/eurheartj/ehac491

• Abstract
• View article

Fast Track Clinical Research

Cost effectiveness of population screening vs. no screening for cardiovascular disease: the Danish Cardiovascular Screening trial (DANCAVAS)

Rikke Søgaard and others

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4392–4402, https://doi.org/10.1093/eurheartj/ehac488

• Abstracts
• View article
• Supplementary data

Editorial

Economic value of multimodal cardiovascular screening

Mark A Hlatky and Philip Greenland

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4403–4405, https://doi.org/10.1093/eurheartj/ehac489

• Abstract
• View article

Fast Track Clinical Research

Dapagliflozin for heart failure according to body mass index: the DELIVER trial

Carly Adamson and others

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4406–4417, https://doi.org/10.1093/eurheartj/ehac481

• Abstracts
• View article
• Supplementary data

Editorial

‘Normal weight’ is really not normal in chronic disease

Stefan D Anker and others

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4418–4420, https://doi.org/10.1093/eurheartj/ehac486

• Abstract
• View article

Fast Track Clinical Research

Empagliflozin in acute myocardial infarction: the EMMY trial

Dirk von Lewinski and others

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4421–4432, https://doi.org/10.1093/eurheartj/ehac494

• Abstracts
• View article
• Supplementary data

Editorial

Putting the puzzle together: SGLT2 inhibitors from prevention to treatment of heart failure

Josephine Harrington and others

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4433–4435, https://doi.org/10.1093/eurheartj/ehac483

• Abstract
• View article

Discussion Forum

Hypernatremia and subclinical chronic kidney disease

Pantelis Sarafidis and others

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4436–4437, https://doi.org/10.1093/eurheartj/ehac367

• Extract
• View article

Making decision about fluid intake: increase or not increase

Natalia I Dmitrieva and others

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Pages 4438–4439, https://doi.org/10.1093/eurheartj/ehac368

• Extract
• View article

Cardiovascular Flashlight

A case of bilateral atrial myxoma straddling the foramen ovale

Jun He and others

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Page 4440, https://doi.org/10.1093/eurheartj/ehac386

• Extract
• View article
• Supplementary data

Pulmonary artery aneurysm and dissection caused by patent ductus arteriosus

Huawei Zhang and others

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Page 4441, https://doi.org/10.1093/eurheartj/ehac438

• Extract
• View article

Erratum

Erratum to: Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Page 4391, https://doi.org/10.1093/eurheartj/ehac425

• Extract
• View article

Corrigendum

Corrigendum to: Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Page 4373, https://doi.org/10.1093/eurheartj/ehac452

• Extract
• View article

Corrigendum to: Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled

European Heart Journal, Volume 43, Issue 41, 1 November 2022, Page 4377, https://doi.org/10.1093/eurheartj/ehac428

• Extract
• View article